Weisen Fan

No ORCID on file · 8 papers in corpus · active 2022-2026

Study types

  • article 3
  • review 3
  • other 2

Condition tags

  • endometriosis 8
  • mesh:D004715 5
  • dysmenorrhea 2
  • infertility 1
  • adenomyosis 1
review 2026
Endometriosis immune microenvironment timing shifts: from immune escape to immune exhaustion
Cell death discovery ·doi:10.1038/s41420-026-02965-8

Endometriosis(EMS) symptoms, progression, and onset are all linked to the patient's immune system dysfunction. Research on immune cells and their molecular mechanisms has long been a prime focus of EMS studies. Nonetheless, the immune envir…

article 2025
Creation of a rat model of ovarian endometriosis: a novel and easy approach to simulating chocolate cysts
Experimental cell research ·doi:10.1016/j.yexcr.2025.114553

Ovarian endometriosis(OEM) is the most common type of endometriosis, but there is still a lack of simple and easy-to-promote animal models. Therefore, it is necessary to establish a feasible animal model of OEM and analyze its pathogenesis.…

article 2025
Novel discovery of geraniol and salvianolic acid B in regulating endometriosis recurrence targets LGALS3/VEGFA via integrating AI and biosensors
·doi:10.1016/j.cej.2025.171649
other 2025
Tellimagrandin II Stimulates Inflammasomes by Causing an Accumulation of 3-Aminopropanal, Which Promotes Apoptosis of Endometriotic Cells While Inhibiting Invasion
Journal of inflammation research ·doi:10.2147/JIR.S558146

BACKGROUND: Endometriosis is frequently treated with Paeoniae Radix. It contains Tellimagrandin II, which has the role of modulating immunity and anti-tumor. Therefore, we will explore the effects of Tellimagrandin II on the apoptosis and i…

other 2025
The Mechanism of Xuanyu Tongjing Decoction Regulating NOD/NFκB Pathway to Inhibit Ectopic Tissue Inflammation to Reduce Ovarian Damage in Rats with Ovarian Endometriosis
Drug design, development and therapy ·doi:10.2147/DDDT.S500129

INTRODUCTION: In traditional Chinese medicine texts, Xuanyu Tongjing Decoction (XYTJD) is a prescribed remedy for premenstrual belly pain and dysmenorrhea. It is currently routinely used to treat ovarian endometriosis (OEM) with good outcom…

review 2024
Molecular mechanism of aberrant decidualization in adenomyosis leading to reduced endometrial receptivity
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1435177

Patients with adenomyosis not only experience a decrease in quality of life as a result of dysmenorrhea and severe monthly flow but they are also rendered infertile. Pregnancy rates are still low among women with adenomyosis, even with assi…

review 2023
Decreased oocyte quality in patients with endometriosis is closely related to abnormal granulosa cells
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1226687

Infertility and menstrual abnormalities in endometriosis patients are frequently caused by aberrant follicular growth or a reduced ovarian reserve. Endometriosis typically does not directly harm the oocyte, but rather inhibits the function …

article 2022
Research into the mechanism of intervention of SanQi in endometriosis based on network pharmacology and molecular docking technology
Medicine ·doi:10.1097/md.0000000000030021

BACKGROUND: By using network pharmacology and molecular docking technology, we have explored the mechanism of action of Sanqi in the treatment of endometriosis (EMS), in order to provide reference for clinical studies of Chinese medicine tr…